January 30, 2019
GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL)
Read More
January 30, 2019
An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer
Read More
January 30, 2019
An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer
Read More
January 30, 2019
Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC
Read More
January 30, 2019
Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC
Read More
January 30, 2019
Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Participants With Chronic Genotype 2 HCV Infection
Read More
January 30, 2019
Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy
Read More
January 30, 2019
UNITY 3: A Japanese Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 in Subjects With Genotype 1 Chronic Hepatitis C
Read More
January 30, 2019
Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)
Read More
January 30, 2019
Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1
Read More
January 30, 2019
Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2
Read More
January 30, 2019
Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3
Read More
Load More
X